Filter
1030
Text search:
Price,
R.
Featured
Recommendations
93
New Publications
242
Language
Document type
No document type
505
Studies & Reports
287
Guidelines
133
Manuals
44
Strategic & Response Plan
25
Fact sheets
14
Training Material
13
Situation Updates
3
Resource Platforms
3
Brochures
1
Infographics
1
Online Courses
1
Countries / Regions
Global
67
South Africa
28
India
27
Nepal
19
Ethiopia
16
Uganda
16
Kenya
16
Ukraine
16
Western and Central Europe
16
Sierra Leone
14
Liberia
14
Africa
14
Congo, Democratic Republic of
13
Philippines
11
Zambia
11
Bangladesh
11
Myanmar / Burma
11
Latin America and the Carribbean
11
Nigeria
10
Syria
10
Ghana
9
South Sudan
9
Tanzania
9
Cambodia
9
Sudan
9
Afghanistan
8
Mozambique
8
Brazil
8
South–East Asia Region
8
Eastern Europe
8
Rwanda
7
Malawi
7
Zimbabwe
6
Namibia
6
Venezuela
6
Russia
6
Guinea
5
Germany
5
East and Southern Africa
5
Middle East and North Africa
5
Cameroon
4
Haiti
4
Benin
4
Botswana
4
Lesotho
4
Eastern Europe and Central Asia
4
Asia
4
Albania
4
Tajikistan
4
North America
4
Jamaica
4
Somalia
3
Pakistan
3
Turkey
3
China
3
Indonesia
3
Angola
3
Sri Lanka
3
West and Central Africa
3
Kyrgyzstan
3
Vietnam
3
Portugal
3
Spain
3
Burkina Faso
2
Senegal
2
USA
2
Chad
2
Thailand
2
Central African Republic
2
Eswatini/ Swaziland
2
North Macedonia
2
Colombia
2
Madagascar
2
Yemen
2
Paraguay
2
Southern Africa
2
Kazakhstan
2
Turkmenistan
2
France
2
United Kingdom
2
Bosnia and Herzegovina
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Jordan
1
Egypt
1
Papua New Guinea
1
Argentina
1
Peru
1
Serbia
1
Ecuador
1
Bhutan
1
North Korea
1
Timor Leste/ East Timor
1
Estonia
1
Lithuania
1
Moldova
1
Japan
1
Denmark
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
298
Clinical Guidelines
107
Public Health
66
Key Resources
54
Women & Child Health
39
Pharmacy & Technologies
19
Capacity Building
5
Toolboxes
Mental Health
106
HIV
94
COVID-19
78
Planetary Health
75
TB
39
Conflict
37
Health Financing Toolbox
34
NCDs
34
Pharmacy
33
Global Health Education
31
AMR
28
Disability
22
NTDs
18
Ebola & Marburg
16
Natural Hazards
16
Malaria
14
Refugee
13
Caregiver
13
Rapid Response
10
Social Ethics
9
Cholera
3
Specific Hazards
3
2.0 Rapid Response
3
Zika
2
Polio
1
South Sudan
1
Typhoon
1
Tax capacity—the policy, institutional, and technical capabilities to collect tax revenue—is part of a deeper process of state building that is essential for achieving the sustainable development goals. This Staff Discussion Note shows that developing countries have made some progress in revenue
...
In the last three decades, health financialization has surged in
several creative ways, yet this growing phenomenon remains surprisingly
unknown, and neglected, in the global health arena. Financialization in the
health domain could be described as the uncontrolled expansion of finance along vari
...
Development finance is at a turning point, as the macroeconomic environment has changed profoundly and the financing gap for low- and middle-income countries has widened. The events that led to this new situation are the multiple crises that the global economy is facing, such as the climate crisis,
...
Achieving financial risk protection for the whole population requires significant financing for health. Health systems in low- and middle-income countries (LMIC) are plagued with persistent underfunding, and recent reductions in official development assistance have been registered. To create fiscal
...
The Council was established in late 2020 by Dr Tedros Adhanom
Ghebreyesus (Director-General, WHO) to provide new economic thinking – reassessing how health and wellbeing are valued, produced and distributed across the economy. An all-female group of 10 distinguished economists and area experts, t
...
Conditioned domestic financing policy, referring to the domestic financing of health projects, programs, and national responses conditioned by global health funding agencies and recipient country governments, is one mechanism to promote sustainability and country ownership. We aim to understand how
...
The COVID-19 pandemic exposed critical gaps in the global response to health crises, particularly in the financing of pandemic prevention, preparedness, response, recovery, and reconstruction. This chapter presents a comprehensive framework for pandemic financing that spans the entire pandemic cycle
...
There has never been a more critical moment to invest in WHO, and strengthen the unique role it plays in global health. Now is the time to sustainably finance WHO and invest in a healthy return for all.
In 2019, the Task Force on Fiscal Policy for Health concluded that taxes on tobacco, alcohol, and sugar-sweetened beverages were a highly effective but greatly underused policy tool to reduce consumption, save lives, and raise domestic resources. The Task Force estimated that if all countries increa
...
Social and Behaviour Change Communication (SBCC) is essential for the effective control, prevention and elimination of malaria. The 2018–2030 Strategic Framework for Malaria SBCC guides countries and partners in strengthening capacities, refining strategies and sharing best practices, all of which
...
The WHO guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate online platform.
The WHO guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-frie
...
Relapsing malaria caused by Plasmodium vivax parasites poses a significant challenge to global malaria elimination efforts. About one third of the population remains at risk of contracting P. vivax malaria, and 85% of P. vivax infections stem from reactivated latent parasites, leading to chronic ana
...
Clinical Pharmacology: Advances and Applications, 2025:17 29–47
Depuis 2010, la lutte contre le paludisme a permis de réaliser des progrès majeurs grâce à la distribution de moustiquaires, au diagnostic rapide, aux traitements à base d'artémisinine (ACT) et aux interventions préventives ciblées.
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN
...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
Despite being a preventable and curable infectious disease, tuberculosis (TB) has continued to elude global controll efforts. In 2023, 8.2 milion people with TB were diagnosed and notified to the WHO, the hightest number ever reported since WHO began tracking.
